Nuclear medicine vendor SMV of Twinsburg, OH, reported last month that it has completed the financial recapitalization plan announced earlier this year (SCAN Special Report June 1997). The deal includes the retirement of about $38 million in corporate
Nuclear medicine vendor SMV of Twinsburg, OH, reported last month that it has completed the financial recapitalization plan announced earlier this year (SCAN Special Report June 1997). The deal includes the retirement of about $38 million in corporate debt, and brings a new shareholder into the company.
The debt was a legacy of Sopha Medical, the French gamma camera vendor that joined forces with Summit Nuclear to form SMV in 1995. SMV owed the debt primarily to CEA, a French government agency that was the majority shareholder in Sopha. That debt has now been converted into equity.
In a separate transaction, investment firm Oracle Strategic Partners of New York City acquired a substantial minority position in SMV in exchange for additional funding. Oracle, which did not have a previous position in the company, now has two seats on SMV's six-seat board.
The transactions provide a controlling interest in SMV to the company's management, led by CEO Jean Plazenet. SMV believes that the moves will eliminate doubts about the company's financial health that have plagued the firm since the merger between Sopha and Summit. In fact, SMV's market share has climbed by several points in recent months, and the company's backlog is booming, according to Bill Bishop, vice president of business development. The company claims the number-three market-share position in the U.S. and the number-one position in Europe. It expects to report a profitable year in 1997, with annual revenues projected to be $85 million.
In other SMV news, the company has commenced delivery of its MPX and SPX series PowerStation computers, which use the IBM RISC System/6000 workstation platform with 64-bit architecture. The new PowerStations come configured with up to a 200-MHz CPU, 128 MB of memory, 2-GB hard drive, and a CD-ROM drive. Netscape's Navigator Web browser software is provided on the MPX and SPX series PowerStation computers, which were demonstrated at the Society of Nuclear Medicine meeting in June (SCAN 5/28/97).
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.